Form CORRESP - Correspondence:
SEC Accession No. 0001599298-25-000018
Filing Date
2025-01-06
Accepted
2025-01-06 16:01:22
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 11893
2 image_0.jpg GRAPHIC 52777
3 image_1.jpg GRAPHIC 30404
  Complete submission text file 0001599298-25-000018.txt   127667
Mailing Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131
Business Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131 305-203-2034
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

EIN.: 371979717 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)